4
Views
7
CrossRef citations to date
0
Altmetric
Main Article

Quantitation of Antibodies against Group B Streptococci, Types Ia, Ib and III in Sera from Different Groups of Individuals: High Antibody Levels in Sera from Venereal Disease Clinic Patients

, , &
Pages 165-169 | Published online: 02 Jan 2015
 

Abstract

Sera from 3 groups of individuals were investigated for antibodies to group B streptococci (GBS) types Ia, Ib and III using radiolabelled protein A: 45 girls, aged 1 to 12 years; 123 non-pregnant gynecological outpatients, aged 15 to 42 years; and 96 female venereological disease (VD) clinic patients, aged 15 to 54 years. The two groups of adults had higher antibody levels against type Ia than the girls, while no difference was found between the two adult groups in this respect. On the other hand, the VD patients had higher levels of antibodies against type Ib than the girls and the gynecological patients; the gynecological patients did not differ from the girls as regards anti-lb antibodies. The antibody levels against type III were higher among the VD clinic patients than among the gynecological patients, who in turn had higher levels than the girls. Thus, the adults showed higher levels of antibodies against 2 of the 3 GBS types than did the girls. Furthermore, the VD clinic patients had higher levels against 2 of the 3 GBS types than the gynecological patients.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.